Search
Now showing items 1-3 of 3
Humoral response after a BNT162b2 heterologous third dose of COVID- 19 vaccine following two doses of BBIBP-CorV among healthcare personnel in Peru
(Sociedad Japonesa de Vacunología, 2023-05)
Background: The inactivated virus vaccine, BBIBP-CorV, was principally distributed across low- and
middle-income countries as primary vaccination strategy to prevent poor COVID-19 outcomes. Limited
information is available ...
Effectiveness of the BBIBP-CorV vaccine in preventing infection and death in health care workers in Peru 2021
(Royal College of Physicians and Surgeons de Glasgow, 2023-03-16)
Background: During 2021, Peru started the vaccination against SARS-CoV-2 using the BBIBP-CorV inactivated virus vaccine for health care workers (HCW). We aim to evaluate the effectiveness of the BBIBP-CorV vaccine to prevent ...
Clinical-epidemiologic variation in patients treated in the first and second wave of COVID-19 in Lambayeque, Peru: A cluster analysis
(International Society for Infectious Diseases, 2022-10)
Objectives: To identify differences in the clinical and epidemiologic characteristics of patients during the first and second waves of the COVID-19 pandemic at the EsSalud Lambayeque health care network, Peru.
Methods: ...